Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue Suppl 2
459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC
Free
Online download statistics by month:
Online download statistics by month: November 2021 to November 2024
Abstract
Full
Pdf
Nov 2021
412
0
40
Dec 2021
78
0
16
Jan 2022
94
0
14
Feb 2022
92
0
24
Mar 2022
202
0
22
Apr 2022
154
0
18
May 2022
120
0
21
Jun 2022
92
0
17
Jul 2022
186
0
9
Aug 2022
146
0
12
Sep 2022
94
0
16
Oct 2022
86
0
11
Nov 2022
96
0
17
Dec 2022
90
0
4
Jan 2023
64
0
7
Feb 2023
56
0
4
Mar 2023
82
0
7
Apr 2023
50
0
12
May 2023
70
0
10
Jun 2023
44
0
8
Jul 2023
68
0
18
Aug 2023
64
0
12
Sep 2023
98
0
8
Oct 2023
80
0
8
Nov 2023
92
0
6
Dec 2023
86
0
3
Jan 2024
24
0
7
Feb 2024
52
0
5
Mar 2024
84
0
7
Apr 2024
96
0
13
May 2024
82
0
9
Jun 2024
68
0
9
Jul 2024
67
0
4
Aug 2024
82
0
10
Sep 2024
126
0
12
Oct 2024
96
0
13
Nov 2024
52
0
8
Total
3625
0
441
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?